Cormorant Asset Management, LP - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 28 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$11,928,000
-24.4%
200,0000.0%2.11%
-19.5%
Q2 2017$15,778,000
-4.9%
200,0000.0%2.62%
+8.6%
Q1 2017$16,588,000
-49.0%
200,000
-51.2%
2.41%
-45.1%
Q4 2016$32,529,000
+1.9%
410,000
-10.1%
4.38%
+24.6%
Q3 2016$31,920,000
+62.6%
455,995
-9.9%
3.52%
+26.5%
Q2 2016$19,628,000
-3.1%
505,995
+1.2%
2.78%
-8.8%
Q1 2016$20,250,000
-42.9%
500,000
+25.0%
3.05%
-28.1%
Q4 2015$35,468,000
+59.7%
400,000
+33.3%
4.24%
+19.6%
Q3 2015$22,209,000
-8.4%
300,0000.0%3.55%
+10.0%
Q2 2015$24,258,000
-19.2%
300,000
-58.1%
3.22%
-30.5%
Q1 2015$30,014,000
+384.1%
716,500
+79.1%
4.64%
+385.1%
Q4 2014$6,200,000
+22.5%
400,0000.0%0.96%
-8.2%
Q3 2014$5,060,000
-11.7%
400,0000.0%1.04%
-31.5%
Q2 2014$5,732,000
+12.4%
400,0000.0%1.52%
+29.5%
Q1 2014$5,100,000400,0001.17%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders